Kymera Therapeutics, Inc.
USD109.32
+1.20 (+1.11%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$106.96
Prev. Close
$108.12
Day Low
$105.00
Day High
$111.96
52W Low
$36.65
52W High
$130.05
Market Cap
$8.99B
Volume
1.68M
| 627,597 |
| $106.50 |
| 26 Jun 2026 | BVF PARTNERS L P/IL | director, other: See Remarks and Footnotes | S-Sale | Disposed | 113,289 | $106.50 |
| 26 Jun 2026 | BVF PARTNERS L P/IL | director, other: See Remarks and Footnotes | S-Sale | Disposed | 51,858 | $106.50 |
| 25 Jun 2026 | Booth Bruce | director | S-Sale | Disposed | 37,179 | $119.71 |
| 25 Jun 2026 | Booth Bruce | director | S-Sale | Disposed | 112,299 | $120.66 |
| 25 Jun 2026 | Booth Bruce | director | S-Sale | Disposed | 40,774 | $121.38 |
| 25 Jun 2026 | Booth Bruce | director | S-Sale | Disposed | 4,977 | $122.67 |
| 25 Jun 2026 | Booth Bruce | director | S-Sale | Disposed | 10,860 | $123.62 |
| 25 Jun 2026 | Booth Bruce | director | S-Sale | Disposed | 11,711 | $124.61 |